ONCOLife Articles
Breakthrough in First-Line Ovarian Cancer Treatment: KEYTRUDA and LYNPARZA
Clinical Trials | 10 December 2024
FDA Grants Accelerated Approval to Bizengri for Treating NRG1+ Pancreatic Cancer and NSCLC
FDA & EMA | 5 December 2024
Fixed-Duration Acalabrutinib Plus Venetoclax Achieves Superior 77% PFS in Untreated CLL
Clinical Trials | 9 December 2024
Adding Blinatumomab to Chemotherapy Extends 96% DF Survival in Pediatric Leukemia
Clinical Trials | 8 December 2024
AI-Driven Cancer Therapy: Recursion Doses First Patient in REC-1245 Trial for Solid Tumors
AI | 6 December 2024
AI-Powered PET/CT Analysis May Predict Side Effects of Immunotherapy in Lung Cancer
AI | 29 November 2024
The FDA Approves IMKELDI, the First Oral Liquid Form of Imatinib, for Leukemia
FDA & EMA | 27 November 2024
SKYSCRAPER-01 Trial Shows Safety of Tiragolumab Plus Atezolizumab in Lung Cancer
Clinical Trials | 26 November 2024
How AI is Shaping Drug Discovery: LP-300 in Lung Cancer Treatment
ONCOLife | 27 November 2024
How Novel Immunotherapy IMNN-001 Could Change Ovarian Cancer Outcomes
ONCOLife | 25 November 2024
FDA Approves Ziihera as First Dual HER2-Targeted Therapy for Biliary Tract Cancer
ONCOLife
22 November 2024
How Oncolytic Viruses Could Be a New Frontier in Transforming Cancer Treatment
ONCOLife
20 November 2024
UK Researchers Launch Groundbreaking Study to Uncover Cancer Survival Secrets
ONCOLife
19 November 2024
FDA Approves MI Cancer Seek Test for Targeted Cancer Therapy
ONCOLife
9 November 2024
IMUNON’s Novel Immunotherapy IMNN-001 Enhances Survival in Ovarian Cancer
Clinical Trials
7 November 2024
Role of CGP Testing in the Management of Cancer Treatment and Personalized Care
ONCOLife
4 November 2024
Transforming Melanoma Treatment with DNA Plasmid Vaccine
ONCOLife
28 October 2024
AI-Powered Cancer Drug LP-184 Receives FDA Fast-Track Designation for Glioblastoma
FDA & EMA
17 October 2024
FDA Approves VYLOY™ as a New Targeted Therapy for Advanced Gastric and GEJ Cancer
FDA & EMA
19 October 2024
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
